by | Mar 25, 2024 | Myeloma News
New research has found that venetoclax, a medication currently approved for leukemia, has benefits for patients with multiple myeloma when used in combination with another drug. This discovery offers a new avenue of treatment options for the currently incurable...
by | Mar 23, 2024 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by | Mar 23, 2024 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by | Mar 19, 2024 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by | Mar 19, 2024 | Myeloma News
Source: Myeloma : nature.com subject feeds Post Content Read More
by | Mar 18, 2024 | Myeloma News
Source: Pharmacy Times articles The decision to vote in favor of idecabtagene vicleucel comes after positive phase 3 trial results demonstrating its efficacy compared with standard regimens. Read More
